000			01374 a2200361 4500
005			20250517053925.0
264		0	_c20151216
008			201512s 0 0 eng d
022			_a0171-2004
024	7		_a10.1007/978-3-319-20825-1_10 _2doi
040			_aNLM _beng _cNLM
100	1		_aKatona, István
245	0	0	_aCannabis and Endocannabinoid Signaling in Epilepsy. _h[electronic resource]
260			_bHandbook of experimental pharmacology _c2015
300			_a285-316 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnimals
650	0	4	_aAnticonvulsants _xadverse effects
650	0	4	_aBrain _xdrug effects
650	0	4	_aCannabidiol _xadverse effects
650	0	4	_aCannabinoid Receptor Agonists _xadverse effects
650	0	4	_aEndocannabinoids _xmetabolism
650	0	4	_aEpilepsy _xdrug therapy
650	0	4	_aHumans
650	0	4	_aMarijuana Smoking _xadverse effects
650	0	4	_aMedical Marijuana _xadverse effects
650	0	4	_aReceptor, Cannabinoid, CB1 _xagonists
650	0	4	_aReceptor, Cannabinoid, CB2 _xagonists
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTreatment Outcome
773	0		_tHandbook of experimental pharmacology _gvol. 231 _gp. 285-316
856	4	0	_uhttps://doi.org/10.1007/978-3-319-20825-1_10 _zAvailable from publisher's website
999			_c25297418 _d25297418